Melissa Eppard is a 46-year-old who was diagnosed with aggressive breast cancer when she was 36. The diagnosis, double mastectomy, chemo, and loss of confidence negatively...
TOPLINE: In a real-world diverse population of patients with early triple-negative breast cancer (TNBC), 34% of patients who received pembrolizumab developed immune-related adverse events — findings...
Philip Morris International recently announced that it is opening a manufacturing facility in Aurora to produce its Swedish Match ZYN nicotine pouches. The company is reported...
Reproductive cancers run in Jeannie Kim’s family. Her dad had pancreatic cancer, her grandfather had gastric cancer, and aunts on both sides of her family have...
A recent British Journal of Cancer evaluated the real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer (mTNBC). Study: Real world study of sacituzumab govitecan...